{{Rsnum
|rsid=1585215
|Gene=NFKB1
|Chromosome=4
|position=102523317
|Orientation=minus
|GMAF=0.292
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NFKB1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.8 | 56.9 | 9.2
| HCB | 28.9 | 66.7 | 4.4
| JPT | 35.6 | 48.9 | 15.6
| YRI | 98.4 | 1.6 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 28.9 | 66.7 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs1585215]] is a SNP in the [[NFKB1]] gene.

A population-based case-control study including 473 cases of [[Hodgkin lymphoma]] concluded that increased risk for the disease was significantly associated with [[rs1585215]]. The odds ratio for [[rs1585215]](G;G) homozygotes was 3.5 (CI: 2.2-5.7, Ptrend = 1.7 x 10(-8)), and for (A;G) heterozygotes, 2.1 (CI: 1.5-2.9).{{PMID|19223558|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}